Tadataka Yamada, President, Global Health Program, Gates Foundation
by Matthew Holt
Private-public partnerships are probably the least feasible option in healthcare provision for Africa. Such a partnership presumes some payback for the private participant in “de-risking the risk” on at least a 50-50 basis. This simply won’t happen. The very reason why so many people, especially children, die each year in preventable and treatable diseases is because they are poor and they cannot pay for the medicines they need, virtually at any price. Even the low prices pharmaceutical companies ask for in emerging world special cases are not affordable to those afflicted and those at risk, particularly in Africa, and neither can most African governments. If Africa is to make any healthcare headway, it’s really up to developed economies to keep their Gleneagles promises of aid, NGOs and such benefactors as Bill Gates. Pharmaceutical companies worldwide are not famous for their altrusim, and asking them to play Russian Roulette with a fully-loaded pistol won’t help.
HTML-Tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>